Medicine
RYVERNA 10 mg/ml
Key ingredient(s)
Crizanlizumab
Available forms & strengths
Request this medicine| Form | Strength | Pack | Route | Icon |
|---|---|---|---|---|
| — | — | — | — |
|
Notes: SAHPRA secureId: CfDJ8C9NQZLkABROpMB-VpZVjLqLBKndNYoJcDd2uxaFidNXU2Sx8-DUCgxu6_hIh-3BuqSLXonnbKGjlYYZQ9OiVw-LJuuGRjsmNxqFtY0I0jmTNt-CqLGYCbjaCJ72aiCkUw | Reg: 54/30.1/0738 | AppNo: 540738 | RegDate: 2020/09/29 | Applicant: Novartis South Africa (Pty) Ltd | API: CRIZANLIZUMAB | Status: Canceled